Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer

Inclusion Criteria: * Female patient aged ≥ 18 years * Women with histologically proven non metastatic breast cancer * ECOG PS ≤ 1 * Patient receiving adjuvant hormonal therapy for at least 1 month (aromatase inhibitor or Tamoxifen ± ovarian function suppression (Luteinizing Hormone Releasing Hormone agonist (LH-RH agonist), ovariectomy...)) * Patient complaining of hot flashes with moderate to severe intensity, affecting quality of life, for at least 1 month before inclusion * Patient agreement not to start another hot flash treatment during the study (allopathic treatment, E vitamin, dietary supplement, phytotherapy, acupuncture...) * Patient able to understand, read and write French * Mandatory affiliation with a health insurance system * Signed, written informed consent Exclusion Criteria: * Ongoing chemotherapy or radiotherapy, or treatment planned to begin during the study * Patient with a condition known to induce hot flashes such as hyperthyroidism, diabetes, adrenal tumor, enteric carcinoid tumor, mastocytosis... * Patient with severe renal failure, severe hepatic failure, or cardiovascular disease * Patient with one of the following contraindications: * known hypersensitivity to one of the components of the study drug * galactose, fructose intolerance * Lapp lactase deficiency, isomaltase invertase deficiency * Glucose or galactose malabsorption syndrome * Follow up impossible because of social, familial, geographical or psychological reasons * Patient suspected of poor compliance with protocol or treatment * Participation in another biomedical research trial in the same indication, or administration of an experimental drug in the same indication in the 30 days before inclusion